DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)

Historical Holders from Q4 2018 to Q3 2025

Symbol
DMAC on Nasdaq
CUSIP
25253X207
Type / Class
Equity / Voting Common Shares, no par value
Shares outstanding
51.9M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
8.76M
Holdings value
$34.2M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
58
Number of buys
39
Number of sells
-25
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TomEnterprise AB 16.28% $30.9M 8.38M TomEnterprise AB Jul 23, 2025
TRILL AB 15.02% +14.5% $45.6M $5.87M 7.76M +14.8% Trill AB Aug 14, 2025
COOPERMAN LEON G 6.3% +5% $22.5M $1.1M 3.27M +5.13% Cooperman Leon G. Sep 30, 2025

Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 118K $814K -$179K $6.87 7
2025 Q2 8.76M $34.2M +$4.95M $3.90 58
2025 Q1 7.51M $28.5M +$2.85M $3.79 57
2024 Q4 6.73M $36.5M +$6.25M $5.43 45
2024 Q3 5.58M $23.3M +$2.25M $4.19 40
2024 Q2 5.06M $14.9M +$1.37M $2.95 32
2024 Q1 4.6M $12.7M +$2.18M $2.77 31
2023 Q4 3.81M $10.8M -$704K $2.84 33
2023 Q3 4.21M $10.9M +$1.92M $2.58 32
2023 Q2 3.49M $15.1M +$4.15M $4.32 28
2023 Q1 2.57M $3.92M +$61.6K $1.53 21
2022 Q4 2.47M $3.9M -$10K $1.58 25
2022 Q3 2.53M $3.13M -$2.36M $1.24 22
2022 Q2 3.67M $7.41M -$804K $2.02 23
2022 Q1 4M $10M -$403K $2.50 25
2021 Q4 3.99M $14.9M +$4.43M $3.73 33
2021 Q3 2.8M $11.2M -$3.55M $4.01 31
2021 Q2 3.78M $16.9M -$12.6M $4.45 37
2021 Q1 5.69M $88.1M +$32.6M $9.15 36
2020 Q4 5.2M $52.6M -$3.66M $10.14 31
2020 Q3 6.7M $28.3M +$15.6M $4.24 28
2020 Q2 0 $0 -$334K 0
2020 Q1 2.92M $8.23M +$5.98M $2.80 17
2019 Q4 801K $3.88M -$429K $4.85 10
2019 Q3 955K $1.97M -$925K $2.06 12
2019 Q2 1.28M $6.36M +$2.58M $4.96 12
2019 Q1 310 $1K -$660K $3.23 1
2018 Q4 1.03M $3M +$3M $2.91 6